From Experimental to Mainstream: TMS, Ketamine and Psychedelic Frontiers

As demand for behavioral health services continues to climb, so too does the adoption of interventional psychiatry like Transcranial Magnetic Stimulation (TMS) and psychedelic therapies like ketamine treatments. Sherry Rais, the CEO and co-founder of Enthea, which provides insurance plans for interventional psychiatry methods like psychedelic-assisted therapy and TMS, said she has seen a 6,000% […]

DEA Signals Readiness to Extend Telehealth and Prescribing Flexibilities for a Fourth Year

Behavioral health and addiction treatment providers are expecting renewed guidance from the Drug Enforcement Administration (DEA) around telehealth prescribing flexibilities for controlled substances, now that the longest government shutdown in the country’s history has been resolved. A pending executive order sent to the Office of Management and Budget titled “Fourth Temporary Extension of COVID-19 Telemedicine […]

Harm Reduction Programs Brace for Cuts Under Trump Administration

This is an exclusive BHB+ story Harm reduction services could face new funding challenges as the practice loses favor with the federal government.  Questions surrounding federal support for substance use disorder (SUD) treatment compounded after the Trump administration consolidated the Substance Abuse and Mental Health Services Administration (SAMHSA) into a new entity. Shortly after, the […]

Centerstone’s CEO-Elect Details How New $1B Nonprofit Will Lead Change in the Field

The Centerstone and Brightli merger marked one of the largest behavioral health transactions of 2025. With an anticipated $1 billion in combined annual revenue and a joint workforce of nearly 10,300 across 360 locations, it also makes the new entity possibly the largest nonprofit in the sector. Dr. C.J. Davis, CEO-elect of the unified organization, […]

Amae Health Gets $25M to Scale Nationwide, Deepen AI Capabilities

San Francisco-based Amae Health has raised $25 million as part of a Series B funding round. The fresh capital will be invested in opening Amae clinics across the U.S., expanding its AI-driven care platform, strengthening partnerships with academic medical centers and supporting research on serious mental illnesses (SMIs).  To date, the SMI treatment provider has […]

Acadia Hits Pause on Multiple De Novo Projects as It Falls Short of Expected Benchmarks

Acadia Healthcare (Nasdaq: ACHC) will hit pause on several de novo development projects and focus on investing in markets with strong reimbursement dynamics. This comes on the heels of Acadia CEO Chris Hunter’s disclosure in September that the company plans to reduce its 2026 expected spending by $300 million. Shortly after, the behavioral health and […]

How Fragmented Data Systems, Financial Pressures Limit Mental Health ROI Calculations

This is an exclusive BHB+ story As fragmented as the behavioral health space may be, achieving a return on investment is something providers, payers and patients generally agree on. Yet, proving ROI looks different just about everywhere, and what it means to different stakeholders can vary. What matters most, though, according to Dr. Mill Brown, […]

Mindbloom Faces Wrongful Death Lawsuit Involving At-Home Ketamine Overdose

At-home ketamine therapy provider Mindbloom has been hit with a wrongful death lawsuit for allegedly failing to properly screen a patient who had a documented history that would have rendered him an unsuitable candidate for treatment. Behavioral Health Business reached out to Mindbloom for comment, but did not receive a response in time for publication. […]